Stage-specific secretion of HMGB1 in cartilage regulates endochondral ossification

Molecular and Cellular Biology

Volumn 27, Issue 16, 2007, Pages 5650-5663

  Taniguchi, Noboru ^a   Yoshida, Kenji ^a   Ito, Tatsuo ^a   Tsuda, Masanao ^a   Mishima, Yasunori ^a   Furumatsu, Takayuki ^a   Ronfani, Lorenza ^b   Abeyama, Kazuhiro ^d   Kawahara, Ko Ichi ^d   Komiya, Setsuro ^d   Maruyama, Ikuro ^d   Lotz, Martin ^a   Bianchi, Marco E ^b,c   Asahara, Hiroshi ^a,e,f  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^d KAGOSHIMA UNIVERSITY   (Japan)

^e NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^f JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOTACTIC FACTOR; COMPLEMENTARY DNA; GELATINASE B; HIGH MOBILITY GROUP B1 PROTEIN; INTERSTITIAL COLLAGENASE; NUCLEAR FACTOR; RNA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; CARTILAGE CELL; CELL DAMAGE; CELL DIFFERENTIATION; CELL INVASION; CYTOKINE PRODUCTION; EMBRYO; EMBRYO DEVELOPMENT; ENCHONDRAL OSSIFICATION; ENDOTHELIUM CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN SECRETION; REGULATORY MECHANISM; TISSUE REPAIR;

ANIMALS; BIOLOGICAL MARKERS; BONE AND BONES; CARTILAGE; CELL DIFFERENTIATION; CELLS, CULTURED; CHEMOTACTIC FACTORS; CHONDROCYTES; EMBRYO; GROWTH PLATE; HMGB1 PROTEIN; HUMANS; MICE; MODELS, BIOLOGICAL; OSTEOBLASTS; OSTEOCLASTS; OSTEOGENESIS;

MUS;

EID: 34547914802     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.00130-07     Document Type: Article

References (60)

1. Abeyama, K., D. M. Stern, Y. Ito, K. Kawahara, Y. Yoshimoto, M. Tanaka, T. Uchimura, N. Ida, Y. Yamazaki, S. Yamada, Y. Yamamoto, H. Yamamoto, S. Iino, N. Taniguchi, and I. Maruyama. 2005. The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism. J. Clin. Investig. 115:1267-1274.
2. Agresti, A., and M. E. Bianchi. 2003. HMGB proteins and gene expression. Curr. Opin. Genet. Dev. 13:170-178.
3. Albrecht, U., G. Eichele, J. A. Helms, and H. Lu. 1997. Molecular and cellular methods in developmental toxicology. CRC Press, Boca Raton, FL.
4. Andersson, U., H. Wang, K. Palmblad, A. C. Aveberger, O. Bloom, H. Erlandsson-Harris, A. Janson, R. Kokkola, M. Zhang, H. Yang, and K. J. Tracey. 2000. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J. Exp. Med. 192:565-570.
5. Ballock, R. T., and A. H. Reddi. 1994. Thyroxine is the serum factor that regulates morphogenesis of columnar cartilage from isolated chondrocytes in chemically defined medium. J. Cell Biol. 126:1311-1318.
6. Binette, F., D. P. McQuaid, D. R. Haudenschild, P. C. Yaeger, J. M. McPherson, and R. Tubo. 1998. Expression of a stable articular cartilage phenotype without evidence of hypertrophy by adult human articular chondrocytes in vitro. J. Orthop. Res. 16:207-216.
7. Blavier, L., and J. M. Delaisse. 1995. Matrix metalloproteinases are obligatory for the migration of preosteoclasts to the developing marrow cavity of primitive long bones. J. Cell Sci. 108(Pt. 12):3649-3659.
8. Bonaldi, T., F. Talamo, P. Scaffidi, D. Ferrera, A. Porto, A. Bachi, A. Rubar telli, A. Agresti, and M. E. Bianchi. 2003. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it toward secretion. EMBO J. 22:5551-5560.
9. Brett, J., A. M. Schmidt, S. D. Yan, Y. S. Zou, E. Weidman, D. Pinsky, R. Nowygrod, M. Neeper, C. Przysiecki, A. Shaw, et al. 1993. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am. J. Pathol. 143:1699-1712.
10. Bustin, M. 1999. Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol. Cell. Biol. 19:5237-5246.
11. Calogero, S., F. Grassi, A. Aguzzi, T. Voigtlander, P. Ferrier, S. Ferrari, and M. E. Bianchi. 1999. The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice. Nat. Genet. 22:276-280.
12. Charoonpatrapong, K., R. Shah, A. G. Robling, M. Alvarez, D. W. Clapp, S. Chen, R. P. Kopp, F. M. Pavalko, J. Yu, and J. P. Bidwell. 2006. HMGB1 expression and release by bone cells. J. Cell Physiol. 207:480-490.
13. Degryse, B., T. Bonaldi, P. Scaffidi, S. Muller, M. Resnati, F. Sanvito, G. Arrigoni, and M. E. Bianchi. 2001. The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. J. Cell Biol. 152:1197-1206.
14. Dumitriu, I. E., P. Baruah, B. Valentinis, R. E. Voll, M. Herrmann, P. P. Nawroth, B. Arnold, M. E. Bianchi, A. A. Manfredi, and P. Rovere-Querini. 2005. Release of high mobility group box 1 by dendritic cells controls T-cell activation via the receptor for advanced glycation end products. J. Immunol. 174:7506-7515.
15. Engsig, M. T., Q. J. Chen, T. H. Vu, A. C. Pedersen, B. Therkidsen, L. R. Lund, K. Henriksen, T. Lenhard, N. T. Foged, Z. Werb, and J. M. Delaisse. 2000. Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J. Cell Biol. 151:879-589.
16. Fukuyama, R., T. Fujita, Y. Azuma, A. Hirano, H. Nakamuta, M. Koida, and T. Komori. 2004. Statins inhibit osteoblast migration by inhibiting Rac-Akt signaling. Biochem. Biophys. Res. Commun. 315:636-642.
17. Gerber, H. P., T. H. Vu, A. M. Ryan, J. Kowalski, Z. Werb, and N. Ferrara. 1999. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat. Med. 5:623-628.
18. Gerstenfeld, L. C., S. D. Chipman, J. Glowacki, and J. B. Lian. 1987. Expression of differentiated function by mineralizing cultures of chicken osteoblasts. Dev. Biol. 122:49-60.
19. Guazzi, S., A. Strangio, A. T. Franzi, and M. E. Bianchi. 2003. HMGB1, an architectural chromatin protein and extracellular signalling factor, has a spatially and temporally restricted expression pattern in mouse brain. Gene Expr. Patterns 3:29-33.
20. Haaijman, A., R. N. D'Souza, A. L. Bronckers, S. W. Goei, and E. H. Burger. 1997. OP-1 (BMP-7) affects mRNA expression of type I, II, X collagen, and matrix Gla protein in ossifying long bones in vitro. J. Bone Miner. Res. 12:1815-1823.
21. Hashimoto, S., R. L. Ochs, F. Rosen, J. Quach, G. McCabe, J. Solan, J. E. Seegmiller, R. Terkeltaub, and M. Lotz. 1998. Chondrocyte-derived apoptotic bodies and calcification of articular cartilage. Proc. Natl. Acad. Sci. USA 95:3094-3099.
22. Henriksen, K., M. Karsdal, J. M. Delaisse, and M. T. Engsig. 2003. RANKL and vascular endothelial growth factor (VEGF) induce osteoclast chemotaxis through an ERK1/2-dependent mechanism. J. Biol. Chem. 278:48745-48753.
23. Holmbeck, K., P. Bianco, J. Caterina, S. Yamada, M. Kromer, S. A. Kuznetsov, M. Mankani, P. G. Robey, A. R. Poole, I. Pidoux, J. M. Ward, and H. Birkedal-Hansen. 1999. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 99:81-92.
24. Imai, S., M. Kaksonen, E. Raulo, T. Kinnunen, C. Fages, X. Meng, M. Lakso, and H. Rauvala. 1998. Osteoblast recruitment and bone formation enhanced by cell matrix-associated heparin-binding growth-associated molecule (HB-GAM). J. Cell Biol. 143:1113-1128.
25. Inada, M., Y. Wang, M. H. Byrne, M. V. Rahman, C. Miyaura, C. Lopez- Otin, and S. M. Krane. 2004. Critical roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in endochondral ossification. Proc. Natl. Acad. Sci. USA 101:17192-17197.
26. Kikuchi, T., T. Matsuguchi, N. Tsuboi, A. Mitani, S. Tanaka, M. Matsuoka, G. Yamamoto, T. Hishikawa, T. Noguchi, and Y. Yoshikai. 2001. Gene expression of osteoclast differentiation factor is induced by lipopolysaccharide in mouse osteoblasts via Toll-like receptors. J. Immunol. 166:3574-3579.
27. Komori, T., H. Yagi, S. Nomura, A. Yamaguchi, K. Sasaki, K. Deguchi, Y. Shimizu, R. T. Bronson, Y. H. Gao, M. Inada, M. Sato, R. Okamoto, Y. Kitamura, S. Yoshiki, and T. Kishimoto. 1997. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755-764.
28. Lefebvre, V., S. Garofalo, G. Zhou, M. Metsaranta, E. Vuorio, and B. De Crombrugghe. 1994. Characterization of primary cultures of chondrocytes from type II collagen/beta-galactosidase transgenic mice. Matrix Biol. 14:329-335.
29. Lian, J. B., G. S. Stein, C. Stewart, E. Puchacz, S. Mackowiak, M. Aronow, M. Von Deck, and V. Shalhoub. 1989. Osteocalcin: characterization and regulated expression of the rat gene. Connect. Tissue Res. 21:61-69.
30. Liu, W., S. Toyosawa, T. Furuichi, N. Kanatani, C. Yoshida, Y. Liu, M. Himeno, S. Narai, A. Yamaguchi, and T. Komori. 2001. Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures. J. Cell Biol. 155:157-166.
31. McLeod, M. J. 1980. Differential staining of cartilage and bone in whole mouse fetuses by alcian blue and alizarin red S. Teratology 22:299-301.
32. Mitola, S., M. Belleri, C. Urbinati, D. Coltrini, B. Sparatore, M. Pedrazzi, E. Melloni, and M. Presta. 2006. Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. J. Immunol. 176:12-15.
33. Nakashima, K., and B. de Crombrugghe. 2003. Transcriptional mechanisms in osteoblast differentiation and bone formation. Trends Genet. 19:458-466.
34. Nakashima, K., X. Zhon, G. Kunkel, Z. Zhang, J. M. Deng, R. R. Behringer, and B. de Crombrugghe. 2002. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108:17-29.
35. Nomura, S., A. J. Wills, D. R. Edwards, J. K. Heath, and B. L. Hogan. 1988. Developmental expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridization. J. Cell Biol. 106:441-450.
36. Okubo, Y., and A. H. Reddi. 2003. Thyroxine downregulates Sox9 and promotes chondrocyte hypertrophy. Biochem. Biophys. Res. Commun. 306:186-190.
37. Ortega, N., D. J. Behonick, and Z. Werb. 2004. Matrix remodeling during endochondral ossification. Trends Cell Biol. 14:86-93.
38. Palumbo, R., M. Sampaolesi, F. De Marchis, R. Tonlorenzi, S. Colombetti, A. Mondino, G. Cossu, and M. E. Bianchi. 2004. Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation. J. Cell Biol. 164:441-449.
39. Park, J. S., D. Svetkauskaite, Q. He, J. Y. Kim, D. Strassheim, A. Ishizaka, and E. Abraham. 2004. Involvement of Toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J. Biol. Chem. 279:7370-7377.
40. Park, K., B. H. Min, D. K. Han, and K. Hasty. 2007. Quantitative analysis of temporal and spatial variations of chondrocyte behavior in engineered cartilage during long-term culture. Ann. Biomed. Eng. 35:419-428.
41. Passalacqua, M., M. Patrone, G. B. Picotti, M. Del Rio, B. Sparatore, E. Melloni, and S. Pontremoli. 1998. Stimulated astrocytes release high-mobility group 1 protein, an inducer of LAN-5 neuroblastoma cell differentiation. Neuroscience 82:1021-1028.
42. Sakiyama, H., T. Nonaka, R. Masuda, N. Inoue, Y. Kuboki, M. Iijima, Y. Hirabayasi, M. Takahagi, K. Yoshida, K. Kuriiwa, M. Yoshida, and S. Imajoh-Ohmi. 2002. Characterization of mineral deposits formed in cultures of a hamster tartrate-resistant acid phosphatase (TRAP) and alkaline phosphatase (ALP) double-positive cell line (CCP). Cell Tissue Res. 309:269-279.
43. Salmivirta, M., H. Rauvala, K. Elenius, and M. Jalkanen. 1992. Neurite growth-promoting protein (amphoterin, p30) binds syndecan. Exp. Cell Res. 200:444-451.
44. Sato, T., M. del Carmen Ovejero, P. Hou, A. M. Heegaard, M. Kumegawa, N. T. Foged, and J. M. Delaisse. 1997. Identification of the membrane-type matrix metalloproteinase MT1-MMP in osteoclasts. J. Cell Sci. 110(Pt. 5):589-596.
45. ScaHdi, P., T. Misteli, and M. E. Bianchi. 2002. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418:191-195.
46. Schlueter, C., H. Weber, B. Meyer, P. Rogalla, K. Roser, S. Hauke, and J. Bullerdiek. 2005. Angiogenetic signaling through hypoxia: HMGB1: an angiogenetic switch molecule. Am. J. Pathol. 166:1259-1263.
47. Stickens, D., D. J. Behonick, N. Ortega, B. Heyer, B. Hartenstein, Y. Yu, A. J. Fosang, M. Schorpp-Kistner, P. Angel, and Z. Werb. 2004. Altered endochondral bone development in matrix metalloproteinase 13-deficient mice. Development 131:5883-5895.
48. Taguchi, A., D. C. Blood, G. del Toro, A. Canet, D. C. Lee, W. Qu, N. Tanji, Y. Lu, E. Lalla, C. Fu, M. A. Hofmann, T. Kislinger, M. Ingram, A. Lu, H. Tanaka, O. Hori, S. Ogawa, D. M. Stern, and A. M. Schmidt. 2000. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 405:354-360.
49. Takami, M., N. Kim, J. Rho, and Y. Choi. 2002. Stimulation by Toll-like receptors inhibits osteoclast differentiation. J. Immunol. 169:1516-1523.
50. Talreja, J., M. H. Kabir, B. F. M., D. J. Stechschulte, and K. N. Dileepan. 2004. Histamine induces Toll-like receptor 2 and 4 expression in endothelial cells and enhances sensitivity to gram-positive and gram-negative bacterial cell wall components. Immunology 113:224-233.
51. Taniguchi, N., K. Kawahara, K. Yone, T. Hashiguchi, M. Yamakuchi, M. Goto, K. Inoue, S. Yamada, K. Ijiri, S. Matsunaga, T. Nakajima, S. Komiya, and I. Maruyama. 2003. High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis Rheum. 48:971-981.
52. Vortkamp, A., K. Lee, B. Lanske, G. V. Segre, H. M. Kronenberg, and C. J. Tabin. 1996. Regulation of rate of cartilage differentiation by Indian hedge-hog and PTH-related protein. Science 273:613-622.
53. Vu, T. H., and Z. Werb. 2000. Matrix metalloproteinases: effectors of development and normal physiology. Genes Dev. 14:2123-2133.
54. Wang, H., O. Bloom, M. Zhang, J. M. Vishnubhakat, M. Ombrellino, J. Che, A. Frazier, H. Yang, S. Ivanova, L. Borovikova, K. R. Manogue, E. Faist, E. Abraham, J. Andersson, U. Andersson, P. E. Molina, N. N. Abumrad, A. Sama, and K. J. Tracey. 1999. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285:248-251.
55. Wang, H., H. Yang, and K. J. Tracey. 2004. Extracellular role of HMGB1 in inflammation and sepsis. J. Intern. Med. 255:320-331.
56. Wang, K., H. Yamamoto, J. R. Chin, Z. Werb, and T. H. Vu. 2004. Epidermal growth factor receptor-deficient mice have delayed primary endochondral ossification because of defective osteoclast recruitment. J. Biol. Chem. 279: 53848-53856.
57. Yamada, S., K. Inoue, K. Yakabe, H. Imaizumi, and I. Maruyama. 2003. High mobility group protein 1 (HMGB1) quantified by ELISA with a monoclonal antibody that does not cross-react with HMGB2. Clin. Chem. 49:1535-1537.
58. Youn, J. H., and J. S. Shin. 2006. Nucleocytoplasmic shuttling of HMGB1 is regulated by phosphorylation that redirects it toward secretion. J. Immunol. 177:7889-7897.
59. Zelzer, E., W. McLean, Y. S. Ng, N. Fukai, A. M. Reginato, S. Lovejoy, P. A. D'Amore, and B. R. Olsen. 2002. Skeletal defects in VEGF(120/120) mice reveal multiple roles for VEGF in skeletogenesis. Development 129:1893-1904.
60. Zhou, Z., D. Immel, C. X. Xi, A. Bierhaus, X. Feng, L. Mei, P. Nawroth, D. M. Stern, and W. C. Xiong. 2006. Regulation of osteoclast function and bone mass by RAGE. J. Exp. Med. 203:1067-1080.